NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,012 | -8.6% | 45,469 | +0.5% | 0.01% | -8.3% |
Q2 2023 | $2,201 | -7.2% | 45,239 | +5.9% | 0.01% | -7.7% |
Q1 2023 | $2,371 | +39.2% | 42,699 | +0.7% | 0.01% | +30.0% |
Q4 2022 | $1,703 | -99.9% | 42,399 | +14.7% | 0.01% | -9.1% |
Q3 2022 | $1,620,000 | +25.2% | 36,969 | +1.3% | 0.01% | +37.5% |
Q2 2022 | $1,294,000 | +3.4% | 36,499 | +18.7% | 0.01% | +14.3% |
Q1 2022 | $1,251,000 | -55.7% | 30,744 | +1.6% | 0.01% | -53.3% |
Q4 2021 | $2,826,000 | -15.6% | 30,259 | +0.7% | 0.02% | -21.1% |
Q3 2021 | $3,350,000 | +8.4% | 30,059 | +10.4% | 0.02% | +5.6% |
Q2 2021 | $3,091,000 | – | 27,230 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |